NVector
Share
Customized CNS Gene Therapy, Diagnostics and Biomarker Services To drive this capability, the company has brought on board Fredric Manfredsson, Ph.D.
nVector’s next generation gene therapy technology is poised to enable revolutionary
treatments for central nervous system (CNS) diseases such as Alzheimer’s, Parkinson’s, ALS, and traumatic brain injury. as Chief Scientific Officer to team with Robert Bowser, Ph.D., nVector’s Chairman of the Board. Together they are directing the development of nVector’s Adeno-Associated Virus platform, which features the first technology to target brain glia (immune) and neuron cells by type and offers better distribution throughout the spinal cord and brain from a single injection. The combination of nVector’s AAV platform and biomarker assays differentiates nVector from other biotechnology companies in the space.
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
Phoenix, AZ
85013
Opening Hours
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |
| Saturday | 10am - 4pm |
Alerts
Be the first to know and let us send you an email when NVector posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.